Johnson & Johnson
-
Johnson & Johnson's COVID-19 Vaccine Protects Less Against the Delta Variant; Experts, CDC Claim
-
Johnson & Johnson Tests Aveeno, Neutrogena Believed to Have Benzene, A Known Carcinogen—Now Faces Recall
-
Johnson & Johnson, AstraZeneca COVID-19 Vaccine Developers Claim Modifications Could Reduce Blood Clotting Risk
-
Johnson & Johnson's COVID-19 Vaccine Links to Guillain-Barré Syndrome, Paralysis, FDA Warns
-
Johnson & Johnson's COVID-19 Vaccine is Protective Against Delta Variants, But Is It Safe for Public Use?
-
'Adenovirus' Ingredient on J&J, AstraZeneca's COVID-19 Vaccines—Why Do They Cause Alarm?
-
Johnson & Johnson COVID-19 Vaccine Halted Due to Signs of Clotting In Patients
-
Pfizer vs Moderna: Comparing Two COVID-19 Vaccines from Side Effects to Storage Requirements
-
Johnson & Johnson Single Shot COVID-19 Vaccine Approved by FDA for 18 Years Old and Above
-
FDA Panel Signs Off Johnson & Johnson One-Shot Vaccine For Covid-19
-
Johnson & Johnson COVID-19 Vaccine Update: Generated Immune Response in Volunteers, Reported Minimal Side-Effects
-
COVID-19 Vaccine: Johnson & Johnson's Human Trials on Hold After 'Unknown Illness'
Most Popular
